Drug – bio-affecting and body treating compositions – Involving sex selection or contraception
Patent
1995-05-25
1997-10-14
Sayala, Chhaya D.
Drug, bio-affecting and body treating compositions
Involving sex selection or contraception
424 854, 514 2, 514 21, 530351, 435 705, A61K 3821
Patent
active
056769423
ABSTRACT:
This invention provides alpha interferon compositions comprising one or a mixture of selected highly antiviral interferon proteins, which compositions are characterized by increased anti-viral activity. These compositions may be used therapeutically in the treatment of viral infection, particularly retroviral or hepatitis infection or as additives to conventional antiviral agents to increase the antiviral potency thereof.
REFERENCES:
patent: 4289690 (1981-09-01), Pestka et al.
patent: 4414150 (1983-11-01), Goeddel
patent: 4503035 (1985-03-01), Pestka et al.
patent: 4530901 (1985-07-01), Weissmann
patent: 4636383 (1987-01-01), Nagabhushan
patent: 4656131 (1987-04-01), Kitano et al.
patent: 4696899 (1987-09-01), Toth et al.
patent: 4780530 (1988-10-01), Teraoka et al.
patent: 4791101 (1988-12-01), Adolf
patent: 4820514 (1989-04-01), Cummins
patent: 4885166 (1989-12-01), Meyer et al.
patent: 4911908 (1990-03-01), Estis et al.
patent: 4975276 (1990-12-01), Innis
patent: 5019382 (1991-05-01), Cummins
patent: 5098703 (1992-03-01), Innis
patent: 5165921 (1992-11-01), Ganesh et al.
patent: 5372808 (1994-12-01), Blatt et al.
patent: 5503828 (1996-04-01), Zesta et al.
D. Goeddel et al, "The Structure of Eight Distinct Cloned Human Leukocyte
D. Bowden et al, "Cloning of Eukaryotic Genes in Single-Strand Phage Vectors: the Human Interferon Genes", Gene, 27:87-99 (1984).
O. Ohara et al, "Anomalous Behavior of Human Leukocyte Interferon Subtypes on Polyacrylamide Gel Electrophoresis in the Presence of Dodecyl Sulfate", FEBS Letters, 211(1):78-82 (Jan., 1987).
A. Friedman-Kien et al, "Natural Interferon Alpha for Treatment of Condylomata Acuminata", JAMA, 259(4):533-538 (Jan. 22/29, 1988).
"Intron A" Physicians Desk Reference, 47th edit., eds. Medical Economics Data, Montvale, NJ, pp. 2194 and 2006 (Dec., 1992).
M. Khan et al, "Inhibition of Growth, Transformation, and Expression of Human Papillomavirus Type 16 E7 in Human Keratinocytes by Alpha Interferons", J. Virol., 67(6):3396-3403 (Jun., 1993).
S. Sperber et al, "Anti-HIV-1 Activity of Recombinant and Hybrid Species of Interferon-alpha", J. Interferon Res., 12(5):363-368 (Oct. 14, 1992).
H. Hochkeppel et al, "Murine AIDS: Effect of a rHu Interferon Alpha-B/D Hybrid (IFN) Against Herpes Simplex Virus Superinfection", J. Cellular Biochem., Suppl. 14D, UCLA Symposia on Molecular and Cellular Biology, Abstracts, 19th Annual Meetings, Abstract L319, p. 136 (Mar. 11-Apr. 6, 1990).
J. Gangemi et al, "9-(2-Phosphonylmethoxyethyl) Adenine in the Treatment of Murine Acquired Immune Deficiency Disease and Opportunistic Herpes Simplex Virus Infections", Antimicrobial Agents and Chemotherapy, 33(11):1864-1868
H. Lane et al, "Interferon-alpha in Patients with Asymptomatic Human Immunodeficiency Virus (HIV) Infection", Annals of Internal Medicine, 112(11):805-811 (Jun. 1, 1990). I!.
K. Zoon, "Purification and Characterization of Human Interferon from Lymphoblastoid (Namalva) Cultures", Meth. Enzymol., 78:457-465 (1981)
M.-J. Liao et al, "Absence of Neutralizing Antibodies to Interferon in Condyloma Acuminata and Cancer Patients Treated with Natural Human Leukocyte Interferon", J. Infect. Dis., 165:757-760 (Apr., 1992).
T. Khavkin et al, "Interactions of Human Monoblastoid Cells (U937) with Sendai Virus and Induction of alpha-Interferon", J. Leukocyte Biology, 1992 Annual Meeting Abstracts, Suppl. 3, Abstr. 137:36 (Oct. 22, 1992).
M. Padhye et al, "Optimization of Interferon Production from Human Peripheral Blood Leukocytes", Keynote Symposia in Growth Factors and Inhibitors, (Jan. 26-Feb. 2, 1992).
G. Linette et al, "Inactivation of HIV-1 in Preparations of Human Interferon by Low pH Treatment", Cancer Therapy and Control, 1:109-120 (1990).
H. Axelrod et al, "Trace Amounts of Murine Immunoglobulin in Affinity Purified Leukocyte Interferon Alpha are not Immunogenic", Biotechnology
R. Wells et al, "Interferon-anl in Children with Recurrent Acute Lymphocytic Leukemia: A Phase I Study of Pharmacokinetics and Tolerance", J. Interferon Res., 8:309-318 (1988).
A. Billiau, "Interferon Therapy: Pharmacokinetic and Pharmacological Aspects", Arch. Virol., 67:121-133 (1981).
G. Dusheiko et al, "Recombinant Leukocyte Interferon Treatment of Cronic Hepatitis B", Hepatology, 5(4):556-560 (1985).
P. Burman et al, "Thyroid Autoimmunity in Patients on Long Term Therapy with Leukocyte-Derived Interferon", J. Clin. Endocrinology and Metabolism, 63(5):1086-1090 (1986).
M. Talpaz et al, "Hematologic Remission and Cytogenic Improvement Induced by Recombinant Human Interferon AlphaA in Chronic Myelogenous Leukemia", New England J. Med., 314(17):1065-1069 (Apr. 24, 1986).
G. Scott et al, "Skin Reactions to Interferon Inoculations are Reduced but not Abolished by Purification", J. Interferon Res., 1(1):79-85 (1980).
F. Barouki et al, "Time Course of Interferon Levels, Antiviral State, 2',5'-Oligoadenylate Synthetase and Side Effects in Healthy Men", J. Interferon Res., 7:29-39 (1987).
R. Wills et al, "Interferon Kinetics and Adverse Reactions after Intravenous, Intramuscular, and Subcutaneous Injection", Clin. Pharmacol. Ther., 35(5):722-727 (May, 1984).
G. Jones et al, "Safety and Tolerance of Recombinant Interferon Alfa-2a (Roferon-A) in Cancer Patients", Cancer, 57:1709-1715 (Apr. 15, 1986).
H.-G. Klingemann et al, "Treatment with Recombinant Interferon (alpha-2beta) Early After Bone Marrow Transplantation in Patients at High Risk for Relapse", Blood, 78(12):3306-3311 (Dec. 15, 1991).
R. Reichel et al, "Clinical Study with Recombinant Interferon Gamma Versus Interferon-Alpha-2c in Patients with Condylomata acuminata", J. STD & AIDS, 3:350-354 (Sep./Oct., 1992).
T. Taguchi, "Clinical Studies of Recombinant Interferon Alfa-2a (Roferon-A) in Cancer Patients", Cancer, 57:1705-1708 (1986).
R. Speigel, "Clinical Overview of Alpha Interferon", Cancer, 59:626-631 (1987).
J. Gangemi et al, "Antiviral Activity of a Novel Recombinant Human II!.
S. Pestka et al, "Interferons and Their Actions", Ann. Rev. Biochem.,
S. Nagata et al, "Synthesis in E. coli of a Polypeptide with Human Leukocyte Interferon Activity", Nature, 284:316-310 (Mar. 27, 1980).
A. Mizrahi, "Production of Human Lymphoblastoid (Namalva) Interferon", Meth. Enzymol., 78:54-68 (1981).
A. Phillips et al, "Large-Scale Production of Human Interferon from Lymphoblastoid Cells", Meth. Enzymol., 119:35-38 (1986).
K. Mogensen et al, "Production and Preparation of Human Leukocyte Interferon", Pharmacol. Ther. C, 1:369-381 (1977).
K. Cantell et al, "Production of Interferon in Human Leukocytes from Normal Donors with the Use of Sendai Virus", Methods Enzymol., 78:29-38 (1981)
B. Horowitz, "Large-Scale Production and Recovery of Human Leukocyte Interferon from Peripheral Blood Leukocytes", Methods Enzymol., 119:39-47 (1986).
P. Weck et al, "Interferons in the Treatment of Genital Human Papillomavirus Infections", Am. J. Med., 85(Suppl 2A):159-164 (Aug. 29,
J. Korenman et al, "Long-Term Remission of Chronic Hepatitis B After Alpha-Interferon Therapy", Annal. Intern. Med., 114(8):629-634 (Apr. 15, 1991).
S. Baron et al, "Special Communications-The Interferons-Mechanisms of Action and Clinical Applications", JAMA, 266(10):1375-1383 (Sep. 11, 1991).
M. Hirsch, "Antiviral Drug Development for the Treatment of Human Immunodeficiency Virus Infections (An Overview)", Am. J. Med., 85(Suppl 2A):182-185 (Aug. 29, 1988).
P. Weck et al, "Antiviral Activity of Bacteria-Derived Human Alpha Interferons Against Encephalomyocarditis Virus Infection of Mice", Infect.
E.-D. Kreuser et al, "Modulation of Integrin Expression by Cytokines on Colon Cancer Cell Lines", Onkologies, 14(Suppl. 2), Abstract No. 270, p. 92 (1991).
H. Harada et al, "Distinction of Two Subtypes of Human Leukocyte Interferon (IFN-a) on B Cell Activation, B Cell Proliferation of Two Subtypes of IFN-a", J. Immunol., 131(1):238-243 (Jul., 1983).
D. Goeddel et al, "Human Leukocyte Interferon Produced by E. coli is
M. Streuli et al, "At Least Three Human Type a Interferons: Structure of a2", Science, 209:1343-1347 (Sep. 19, 1980).
A. Lok et al, "Interferon Antibodies May Negate the A
DiPaola Mario
Ferencz-Biro Katalin
Liao Mei-June
Rashidbaigi Abbas
Testa Douglas
Interferon Sciences, Inc.
Sayala Chhaya D.
LandOfFree
Composition containing human alpha interferon species proteins a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition containing human alpha interferon species proteins a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition containing human alpha interferon species proteins a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1553047